Categories: News

Ansys Listed in AWS “ICMP” for the US Federal Government

Ansys STK is now available to US Government Customers in ICMP

PITTSBURGH, July 9, 2024 /PRNewswire/ — Ansys (NASDAQ: ANSS) a global leader in engineering simulation software solutions, today announced that it is listing Ansys STKin the AWS Marketplace for the US Intelligence Community (ICMP). ICMP is a curated digital catalog from Amazon Web Services (AWS) that makes it easy to discover, purchase, and deploy software packages and applications from vendors that specialize in supporting government customers.

Ansys’ offerings include a broad array of common software infrastructure, developer tools, and business software products, with the categories of products and vendors growing over time. Ansys STK is designed to empower customers to model, analyze, visualize, and simulate high-fidelity satellites, spacecraft, and other critical aerospace and defense systems within their operational environments.

“Our customers face incredible challenges completing projects on time and within budget — one substantial hurdle is ensuring a distributed team can seamlessly access the same resources,” said Kevin Flood, vice president of digital mission engineering at Ansys. “Ansys now offers the gold standard in digital mission engineering simulation solutions on ICMP. This seamless accessibility eases pain points around navigating approval processes and file sharing, allowing users to harness the power of STK from any device, anywhere.”

With STK, engineers can model complex systems inside a realistic, simulated 3D environment that includes high-resolution terrain, imagery, radio frequency, and more. It enables users to simulate entire system-of-systems in action and gain a clear understanding of behavior and mission performance.

/ About Ansys

Our Mission: Powering Innovation that Drives Human Advancement

When visionary companies need to know how their world-changing ideas will perform, they close the gap between design and reality with Ansys simulation. For more than 50 years, Ansys software has enabled innovators across industries to push boundaries by using the predictive power of simulation. From sustainable transportation to advanced semiconductors, from satellite systems to life-saving medical devices, the next great leaps in human advancement will be powered by Ansys.

Ansys and any and all ANSYS, Inc. brand, product, service and feature names, logos and slogans are registered trademarks or trademarks of ANSYS, Inc. or its subsidiaries in the United States or other countries. All other brand, product, service and feature names or trademarks are the property of their respective owners.

ANSS–T

/ Contacts

Media 

Mary Kate Joyce

724.820.4368

marykate.joyce@ansys.com

Investors

Kelsey DeBriyn

724.820.3927

kelsey.debriyn@ansys.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ansys-listed-in-aws-icmp-for-the-us-federal-government-302190974.html

SOURCE Ansys

Staff

Recent Posts

Nano Labs Announces Receipt of Deficiency Letters from Nasdaq

HANGZHOU, China, July 12, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or…

4 hours ago

Inhance Technologies’ Statement in Response to EPA’s Section 6 Approach on Fluorination of Plastic Containers

HOUSTON, July 12, 2024 /PRNewswire/ -- Inhance Technologies welcomes the opportunity to engage with the…

10 hours ago

Global High-Throughput Screening (HTS) Market to Reach USD 50.2 Billion by 2029: Opportunities, Challenges, and Growth Drivers | MarketsandMarkets™

CHICAGO, July 12, 2024 /PRNewswire/ -- The global high-throughput screening market is poised for substantial growth,…

10 hours ago

PPG Biosensors Market to be dominated by Smartwatches Segment to reach USD 1001.73 Mn by 2030- Says Stellar Market Research

PUNE, India, July 12, 2024 /PRNewswire/ -- Stellar Market Research, a leading Healthcare business research…

10 hours ago

ImmuneAGE Bio launches to rejuvenate the immune system targeting bone marrow stem cells

SAN JUAN, Puerto Rico and LAUSANNE, Switzerland, July 12, 2024 /PRNewswire/ -- ImmuneAGE Bio raised…

10 hours ago